Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
about
Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugsOral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulationsFormulation and evaluation of matrix type mucoadhesive tablets aimed at treating oral aphtha.Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions.Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development.Maintenance of immunological homeostasis by Indukantha ghritha in patients with recurrent upper respiratory tract infections-a pilot study.Effect of ingested lipids on drug dissolution and release with concurrent digestion: a modeling approach.Experimental design-based optimization of lipid nanocarrier as delivery system against Mycobacterium species: in vitro and in vivo evaluation.Lipid-Based Drug Delivery Systems.Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.Self-microemulsifying drug-delivery system for improved oral bioavailability of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol: preparation and evaluation.New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.Functions of lipids for enhancement of oral bioavailability of poorly water-soluble drugs.The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs.Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.Standardization of Nanoparticle Characterization: Methods for Testing Properties, Stability, and Functionality of Edible Nanoparticles.Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations.Self-Microemulsifying Drug Delivery Systems: An Attractive Strategy for Enhanced Therapeutic Profile.From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS).Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view.Candesartan cilexetil loaded nanodelivery systems for improved oral bioavailability.Review and analysis of FDA approved drugs using lipid-based formulations.Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines.Novel lipid-free nanoformulation for improving oral bioavailability of coenzyme Q10.Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes.Optimization of Landscape Phage Fusion Protein-Modified Polymeric PEG-PE Micelles for Improved Breast Cancer Cell Targeting.The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations.The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane.Spontaneous emulsification of nifedipine-loaded self-nanoemulsifying drug delivery system.Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations.Indomethacin-5-fluorouracil-methyl ester dry emulsion: a potential oral delivery system for 5-fluorouracil.In vitro lipolysis and intestinal transport of β-arteether-loaded lipid-based drug delivery systems.Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution.Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.Augmented bioavailability of felodipine through an α-linolenic acid-based microemulsion.In vitro/in silico approach in the development of simvastatin-loaded self-microemulsifying drug delivery systems.Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions.Modern prodrug design for targeted oral drug delivery.Helix aspersa gelatin as an emulsifier and emulsion stabilizer: functional properties and effects on pancreatic lipolysis.Modulation of lipid digestibility using structured emulsion-based delivery systems: comparison of in vivo and in vitro measurements.
P2860
Q26774831-5D3F2D73-B87E-4E0E-8B1A-A6D18D4E121DQ28534686-15779F0B-F4D5-41F5-AD3E-B5D7FAF1E4A6Q33403041-6CBD9ACD-3C25-4E2B-AA7B-4D1D0153AF90Q33952771-4BC7CB0F-2163-4441-94A8-F5943CF0134FQ34273688-0CD3831D-3B8A-4322-ACB0-E51FC720B982Q34414168-20844598-D9F3-4CA7-A3B0-093C8C14A342Q34799545-D044EA54-D200-444B-901A-2E9D1EE199D6Q36092898-FB9D729D-ED26-460A-B4D1-C0375CA04A11Q36112195-261ADAA3-D2FC-44AC-8D0C-110F6492E4C8Q37066550-744D3C84-F896-415D-AECF-A79E377111A7Q37591913-2CBF7064-1A94-4039-A9A2-A82A4A54253CQ37805592-C976BADC-B532-4A0F-A928-2591A8BC63E5Q37965173-8E5E0BAA-8EE9-468A-BE66-79A17D183A43Q37990748-D86CC376-99A2-4A6D-9502-C88BB8A71221Q38199539-A449DAE0-AD3B-4BAE-AED4-B9342AFD1004Q38409560-1E48CC5C-372D-426C-9F79-D78F0F520C3FQ38874008-A2CBE6FA-188C-47A0-AF0F-768F92297D6BQ38887547-919A4602-8E40-4AEA-B128-2B176475E98CQ38916539-573C60DE-6018-4379-A3BC-685163298BD1Q38967883-403DBC37-4693-43B0-9B6E-06009D0EE67CQ39089042-51E92661-B223-4A9E-B6FD-288ACCB62677Q39411779-26F4AED4-34B9-4FC5-9D05-970828A52C6DQ41003488-9F402556-6DF8-4F9B-AF04-F712CFBFA32CQ41060608-5D9993E9-3559-40EF-ACD2-14B5689B364BQ41201713-DBAD08BB-C85D-45A8-AEB0-7D921612FC9DQ41257114-38604120-5F1A-4C1F-B17E-0BBC77BF1D5EQ41889403-EF908139-558B-4EE8-8E9C-6923181A4DF1Q41986961-7F407585-B9C0-4F19-B81E-F7B8FA40059FQ41987623-45E6B7DF-BCB0-4D31-B46C-6846230E6B7FQ42233383-9CE69501-3B5C-4251-BFF5-655B763F5FC8Q43171581-93065772-87A2-4D71-9B36-EE870AC4128EQ44243385-C118E2BD-AA79-4DD2-9DBF-D3BC21786AF1Q45887220-0DC8B3F9-C1EC-446E-A1AE-ECBAA2A7AFA2Q47756300-36764BED-5E69-4E95-A10C-13E03948770CQ47769665-28D90A9C-6DF7-44B8-AFB6-4E7EF5F8DA91Q48573264-EA9AB11E-A780-4577-85D9-0436E20A0D95Q48627689-8D07CBBF-4981-48E4-A826-FCE09E133CE9Q51042522-03E8B548-7286-483E-965D-D5C21BEAA1DFQ51677922-113BD2A8-54E9-4829-9150-7C1B45A6DCF5Q52621803-230F46C5-DC81-4207-BA4A-EBFC48A89908
P2860
Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rationalizing the selection of ...... of poorly water soluble drugs.
@en
Rationalizing the selection of ...... of poorly water soluble drugs.
@nl
type
label
Rationalizing the selection of ...... of poorly water soluble drugs.
@en
Rationalizing the selection of ...... of poorly water soluble drugs.
@nl
prefLabel
Rationalizing the selection of ...... of poorly water soluble drugs.
@en
Rationalizing the selection of ...... of poorly water soluble drugs.
@nl
P1476
Rationalizing the selection of ...... of poorly water soluble drugs.
@en
P2093
Amnon Hoffman
Arik Dahan
P356
10.1016/J.JCONREL.2008.03.021
P407
P577
2008-04-01T00:00:00Z